The BioCode® Respiratory Pathogen Panel* is a qualitative multiplexed nucleic acid-based in vitro diagnostic test that is capable of the simultaneous detection and identification of nucleic acids from multiple viruses and bacteria extracted from nasopharyngeal swab (NPS) samples obtained from individuals with signs and/or symptoms of respiratory tract infection.
The BioCode® Respiratory Pathogen Panel can identify the following pathogens:
| Viruses |
|
| Bacteria |
|
| Internal Control |
|
Reach out to Applied BioCode to get more information about ordering this product.
Part No. 63-R0001
*The BioCode® Respiratory Pathogen Panel is US FDA 510(k) cleared in the US and CE Mark in Europe. The CE Mark for the BioCode® Respiratory Pathogen Panel includes all the targets listed except for Chlamydia pneumoniae.
